Locations
Netherlands · England, UK · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2016
Peptone is a biotechnology company that specializes in creating novel small-molecule therapeutics targeting intrinsically disordered proteins (IDPs). Utilizing advanced AI and experimental physics, Peptone addresses the challenge of drugging proteins that are difficult to model, particularly those that Alpha Fold 3 cannot accurately predict. The company is positioned to make significant contributions to the treatment of diseases linked to protein dysfunction, leveraging its unique technology to provide insights into druggable pockets of disordered proteins. Peptone has gained recognition in the biotech community, being featured in Nature Biotechnology and selected as a top academic spinout in 2023, indicating strong market traction and potential for growth.
Something looks off?